US President Barack Obama with Indian Prime Minister Manmohan Singh. Official White House Photo by Pete Souza
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.
If you have already subscribed please login.
If you have any technical issues please email tech support.
US, patent, drugs, pharmaceuticals, evergreening, compulsory licence, AFTI, India, US
